PROGNOSTIC SIGNIFICANCE OF SARCOPENIA IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RITUXIMAB PLUS CHOP (R-CHOP)

被引：0
|
作者：
Go, S. I. [1 ]
Park, M. J. [2 ]
Kim, H. G. [1 ]
Kang, M. H. [1 ]
Lee, G. W. [1 ]
机构：
[1] Gyeongsang Natl Univ, Sch Med, Internal Med, Jinju, South Korea
[2] Gyeongsang Natl Univ, Sch Med, Radiol, Jinju, South Korea
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1682
引用
收藏
页码：686 / 687
页数：2
相关论文
共 50 条
  • [31] BASELINE RENAL FUNCTION AS A PROGNOSTIC INDICATOR IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH R-CHOP IMMUNOCHEMOTHERAPY
    Hong, J.
    Lee, S.
    Park, J.
    Ahn, J. Y.
    Jung, J. Y.
    Lee, J. H.
    [J]. HAEMATOLOGICA, 2016, 101 : 690 - 690
  • [32] Prognostic impact of pretreatment albumin to globulin ratio in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Kim, Seok-Hyun
    Go, Se-Il
    Seo, Jangho
    Kang, Myoung Hee
    Park, Sung Woo
    Kim, Hoon-Gu
    Lee, Gyeong-Won
    [J]. LEUKEMIA RESEARCH, 2018, 71 : 100 - 105
  • [33] Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP
    Cho, Kyoung Min
    Keam, Bhumsuk
    Ha, Hyerim
    Kim, Miso
    Jung, Jae-Woo
    Song, Woo-Jung
    Kim, Tae Min
    Jeon, Yoon Kyung
    Kang, Hye-Ryun
    Kim, Dong-Wan
    Kim, Chul Woo
    Heo, Dae Seog
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (04): : 885 - 893
  • [34] Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
    Mounier, N
    Briere, J
    Gisselbrecht, C
    Emile, JF
    Lederlin, P
    Sebban, C
    Berger, F
    Bosly, A
    Morel, P
    Tilly, H
    Bouabdallah, R
    Reyes, F
    Gaulard, P
    Coiffier, B
    [J]. BLOOD, 2003, 101 (11) : 4279 - 4284
  • [35] MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
    Alencar, Alvaro J.
    Malumbres, Raquel
    Kozloski, Goldi A.
    Advani, Ranjana
    Talreja, Neha
    Chinichian, Shideh
    Briones, Javier
    Natkunam, Yasodha
    Sehn, Laurie H.
    Gascoyne, Randy D.
    Tibshirani, Rob
    Lossos, Izidore S.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (12) : 4125 - 4135
  • [36] Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Testoni, Monica
    Kwee, Ivo
    Greiner, Timothy C.
    Montes-Moreno, Santiago
    Vose, Julie
    Chan, Wing C.
    Chiappella, Annalisa
    Baldini, Luca
    Ferreri, Andres J. M.
    Gaidano, Gianluca
    Mian, Michael
    Zucca, Emanuele
    Bertoni, Francesco
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (02) : 274 - 277
  • [37] Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOP
    Castillo, Jorge J.
    Sinclair, Natalie
    Beltran, Brady E.
    Song, Moo-Kon
    Ilic, Ivana
    Leppa, Sirpa
    Nurmi, Heidi
    Seki, Ritsuko
    Uccella, Silvia
    Li, Jun-Min
    Treaba, Diana O.
    Stachurski, Dariusz
    Butera, James N.
    [J]. LEUKEMIA RESEARCH, 2013, 37 (04) : 386 - 391
  • [38] Use of the Lymphgen Tool in a Cohort of Patients with Diffuse Large B-cell Lymphoma Treated with R-CHOP
    Jackson, Ryan
    Perry, Anamarija
    Herrera, Alex
    Bedell, Victoria
    Murata-Collins, Joyce
    Rahimi, Nina
    Pillai, Raju
    Chan, Wing
    Weisenburger, Dennis
    Song, Joo
    [J]. MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 845 - 846
  • [39] Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma
    Yoshiki Terada
    Hirohisa Nakamae
    Ran Aimoto
    Hiroshi Kanashima
    Erina Sakamoto
    Mizuki Aimoto
    Eri Inoue
    Hideo Koh
    Takahiko Nakane
    Yasunobu Takeoka
    Masahiko Ohsawa
    Ki-Ryang Koh
    Takahisa Yamane
    Yoshitaka Nakao
    Kensuke Ohta
    Atsuko Mugitani
    Hirofumi Teshima
    Masayuki Hino
    [J]. Journal of Experimental & Clinical Cancer Research, 28
  • [40] FcγRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP plus rituximab (R-CHOP)
    Camilleri-Broët, S
    Mounier, N
    Delmer, A
    Brière, J
    Casasnovas, O
    Cassard, L
    Gaulard, P
    Christian, B
    Coiffier, B
    Sautès-Fridman, C
    [J]. LEUKEMIA, 2004, 18 (12) : 2038 - 2040
12345